Two Sigma Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Buy
86,140
+32,160
+60% +$81.7K 0.02% 1023
2026
Q1
$106K Buy
53,980
+22,241
+70% +$52.2K 0.01% 1164
2025
Q4
$86K Buy
31,739
+19,628
+162% +$64.4K 0.01% 998
2025
Q3
$51.2K Sell
12,111
-31,777
-72% -$140K 0.01% 984
2025
Q2
$219K Buy
43,888
+12,551
+40% +$54.5K 0.03% 871
2025
Q1
$138K Buy
31,337
+9,853
+46% +$46.2K 0.02% 898
2024
Q4
$99.9K Buy
+21,484
New +$118K 0.01% 1100
2022
Q4
Sell
-17,450
Closed -$86K 2818
2022
Q3
$81K Buy
+17,450
New +$110K ﹤0.01% 2124
2022
Q1
Sell
-10,835
Closed -$354K 2241
2021
Q4
$354K Buy
+10,835
New +$436K 0.02% 713

Other funds holding GDRX

Two Sigma Securities's GDRX Position: Q2 2026 in Review

Two Sigma Securities increased its GoodRx Holdings (GDRX) stake by 60% in Q2 2026, buying an estimated $81.7K and bringing the position to 86,140 shares worth $248K. The position accounts for 0.02% of the portfolio, ranked #1023.

Two Sigma Securities first reported a position in GDRX in Q4 2021 and has held it in 9 quarters since. The position peaked at $354K in Q4 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Two Sigma Securities held 86,140 shares of GoodRx Holdings worth $248K as of Q2 2026.
  • Two Sigma Securities bought 32,160 GoodRx Holdings shares in Q2 2026, an estimated $81.7K.
  • GoodRx Holdings made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1023 holding.
  • Two Sigma Securities first reported a position in GoodRx Holdings in Q4 2021 and has held it in 9 quarters since.
  • Two Sigma Securities's GoodRx Holdings position peaked at $354K in Q4 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.